Crinone Gel
Product Images NDC 0023-6151

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Crinone (NDC 0023-6151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula (Crinone 01)

Chemical structure diagram of progesterone, the active ingredient in Crinone vaginal gel. The diagram shows the molecular framework including carbon rings and functional groups characteristic of progesterone.*

FDA Label Image

Figure A (Crinone 02)

An instructional diagram showing components of a vaginal gel applicator kit for Crinone progesterone gel. It includes a wrapper, an applicator tube, a plunger, and a twist-off cap, labeled clearly to identify each part.*

FDA Label Image

Figure B (Crinone 03)

An instructional line drawing labeled Figure B showing a hand holding a vaginal applicator for dispensing gel medication, partially removed from its wrapper. The image demonstrates how to hold and prepare the applicator for use.*

FDA Label Image

Figure C (Crinone 04)

An instructional illustration showing two hands holding and preparing a vaginal gel applicator, consistent with the use of Crinone (progesterone) gel. The image demonstrates how to position the applicator before use.*

FDA Label Image

Figure D And Figure E (Crinone 05)

Instructional illustrations showing a hand twisting off the cap of a tube and another hand twisting the top of a container, likely demonstrating how to open and prepare the Crinone vaginal gel applicator for use.*

FDA Label Image

Figure F (Crinone 06)

Illustration showing a person lying on their back with knees bent and feet flat, likely demonstrating a position for vaginal drug administration or related use instructions for Crinone progesterone vaginal gel.*

FDA Label Image

Figure G (Crinone 07)

An instructional line drawing illustrating the vaginal administration of a gel medication using an applicator, showing a hand inserting the applicator into the vaginal canal. This image is consistent with directions for vaginal gel products such as Crinone progesterone gel.*

FDA Label Image

Figure H (Crinone 08)

An instructional line drawing illustrating the vaginal administration of a gel medication. The image shows a hand inserting an applicator into the vaginal canal to deliver the gel dose. This diagram corresponds to administration techniques relevant for vaginal gel products such as Crinone (progesterone).*

FDA Label Image

Crinone (progesterone Gel) 4%6 Single-use Prefilled Applicatorsndc 0023-6150-04 (Crinone 09)

Crinone 4% progesterone gel vaginal dosage form packaging label from Allergan, Inc. The box shows 1.3 g gels delivering 45 mg progesterone each, intended for vaginal use only. The label includes product name, strength, directions stating single-use applicators, and manufacturing information.*

FDA Label Image

Crinone(progesterone Gel) 8%15 Single-use Prefilled Applicatorsndc 0023-6151-08 (Crinone 0a)

Packaging label for Crinone 8% vaginal gel containing progesterone 8%. The label shows the product name, strength, dosage form as gel for vaginal use, and the Allergan, Inc. labeler. It includes product usage instructions, barcode, and regulatory information on a white background with purple and gold text accents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.